Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,863
Sort by:
Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
US$ 3,800.00
... , and Keytruda? What is the global market for cancer vaccines? What is the global market for cytokines in cancer immunotherapy? The projected market values for ... CAR T therapeutics be approved? What are the current regulations for immunotherapies in USA, Europe & Japan? What are the main manufacturing steps in ...
July 2015
317 pages
2015 Emerging Cancer Diagnostic Technologies, and Strategic Profiles of Leading Suppliers
US$ 2,800.00
... /complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products ...
July 2015
185 pages
US Breast Cancer Therapy Market Opportunity Analysis
US$ 2,400.00
... Breast Cancer Incidence & Prevalence US Breast Cancer Therapy Market Overview US Breast Cancer Drug Clinical Pipeline by Company & Phase US Breast Cancer Drug Clinical Pipeline: 251 Drugs Majority Drugs in Phase-II Trials: 73 Drugs Marketed Breast Cancer Drugs in US: 32 Drugs Breast Cancer ...
July 2015
700 pages
Non-Small Cell Lung Cancer: KOL Insight
US$ 7,495.00
Non-Small Cell Lung Cancer: KOL Insight offers detailed expert opinion on the continuing evolution of the ... , including checkpoint inhibitors, vie for approval in this lucrative space. Non-Small Cell Lung Cancer: KOL Insight presents a comprehensive qualitative review of targeted therapies in the market ...
June 2015
2015-2019 European Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 15,760.00
... European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers ... in five major European countries. Current and Emerging Products- Review of over 200 current and emerging cancer diagnostic tests,including:- Biochemical Markers- Oncogenes ...
June 2015
820 pages
2015-2019 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 27,800.00
... can be custom-tailored to your specific information needs and budget. 2015-2019 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies ... diagnostic product suppliers by individual test and country. Five-year test volume and sales forecasts for major tumor markers by country and market segment ...
June 2015
1200 pages
2015-2019 European Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK
US$ 15,760.00
... business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy ... basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological ...
June 2015
820 pages
2015-2019 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Country Sales Forecasts, and Strategic Profiles of Leading Suppliers
US$ 6,000.00
... cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer ... significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new ...
June 2015
510 pages
2015-2019 World Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
US$ 27,800.00
... is available by country, section, market segment, and can be custom tailored to your specific information needs and budget. 2015 2019 World Cancer Diagnostics Market: Supplier Shares, Country Forecasts ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
June 2015
1200 pages